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Abstract 
 
Chagas disease constitutes a major public health problem in Latin America. Human breast milk is a 
biological sample of great importance for the analysis of therapeutic drugs, as unwanted exposure 
through breast milk could result in pharmacological effects in the nursing infant. Thus, the goal of 
breast milk drug analysis is to inquire to which extent a neonate may be exposed to a drug during 
lactation. 
In this work, we developed an analytical technique to quantify benznidazole and nifurtimox (the 
two antichagasic drugs currently available for the medical treatment) in human breast milk, with a 
simple sample pre-treatment followed by an ionic-liquid-based dispersive liquid–liquid 
microextraction combined with high-performance liquid chromatography and UV detection. For this 
technique, the ionic liquid 1-octyl-3-methylimidazolium hexafluorophosphate has been used as the 
“extraction solvent”. A central composite design was used to find the optimum values for the 
significant variables affecting the extraction process: volume of ionic liquid, volume of dispersant 
solvent, ionic strength, and pH. At the optimum working conditions, the average recoveries were 77.5 
and 89.7%, the limits of detection were 0.06 and 0.09 μg mL-1 and the inter-day reproducibilities were 
6.25 and 5.77% for benznidazole and nifurtimox, respectively. The proposed methodology can be 
considered sensitive, simple, robust, accurate, and green. 
 
1 Introduction 
 
Chagas disease is endemic in Central and South America. Approximately 16–18 million 
people are infected with Trypanosoma cruzi (T. cruzi) and 100 million are at risk of infection [1–5]. 
Two drugs are available for the etiological treatment of Chagas disease: nifurtimox (NFX) and 
benznidazole (BNZ) [6,7]. Currently, NFX and BNZ are used in Argentina, Brazil and Uruguay to 
treat the acute or indeterminate chronic phases of Chagas disease [1,4,8,9]. These drugs are widely 
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accepted for the treatment of the acute phase of the disease [2,4,7]. However, their use during the 
chronic phase remains controversial [4,7,10]. 
The congenital route of infection might be relevant to endemic as well as non-endemic areas 
in future years after migration of infected individuals. Public health policies have been implemented 
in endemic areas with the aims of identifying pregnant women positive for T. cruzi, as well as 
promptly treating infected children immediately after parasitological and serological confirmation 
[1,2,8]. It is important to emphasize that the duration of both NFX and BNZ chemotherapeutic effects, 
as well as its toxicity, are fundamentally controlled by its reductive metabolism in many organs and 
the feces [11–13]. 
Human breast milk is a biological sample of great importance for the analysis of therapeutic 
drugs, as unwanted exposure through breast milk could result in pharmacologic effects in the nursing 
infant. Human breast milk is characterized by a high content of proteins, lipids, and carbohydrates 
which may be vary significantly in composition and concentration [14] depending on several factors 
including stage of lactation, breastfeeding routine, age, diet, and others [15]. These variables can 
affect the recovery of an extracted drug, the analytical method precision, the accuracy, and the sample 
compatibility with a subsequent chromatographic technique [14]. 
Drug transfer from plasma into breast milk occurs primarily by passive diffusion depending 
on molecular weight, drug ionization, lipid solubility, protein binding, and mammary blood flow [16–
19]. However, it remains unknown to what extent NFX or BNZ are transported into breast milk. 
Without this knowledge, most physicians who treat adult patients with Chagas disease refuse to treat 
women during lactation. 
Several reports have been published on detection methods for BNZ in biological fluids. The 
different procedures used in the literature have been detailed in our previous work [20]. Limits of 
detection between 0.04 and 0.14 μg mL-1 and RSD% between 1.3 and 10% were obtained, with 
recoveries from 70 to 97%. Recently, Martínez et al. have published an analytical procedure to 
determine BNZ in urine by UHPLC–MS/MS with a simple sample pretreatment consisting of a LLE 
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with dichloromethane [21]. The methodology is quick, reproducible and selective but, although is 
sensitive, the detection limit (0.75 μg mL-1) resulted to be similar to others previously published in the 
literature due to a serious matrix effect (90% of signal suppression) which affected the ESI-MS/MS 
detector. Up to our knowledge, the only published paper about determination of BNZ in human breast 
milk is that corresponding to Marsón et al. [22]. They developed a simple and fast RP-HPLC–UV 
method with a sample pretreatment that involves acid protein precipitation followed by tandem 
microfiltration. The procedure has proven to be robust, quite reproducible and sensitive with a LOD 
of 0.3 μg mL-1 and a recovery of 70%. 
In the case of NFX, a few methods also detailed in our previous work [20] have been 
published for its determination in biologic fluids. Quantitative determinations of the drug at a 
sensitivity of at least 0.5 mg mL-1 were reported [23]. These studies resulted in the development of an 
easy sample-preparation procedure for pharmacokinetic studies in patients with chronic renal failure 
[23]. However, no analytical methods have been specifically reported for NFX analysis in human 
breast milk. 
Dispersive liquid–liquid microextraction (DLLME) is a novel sample preparation technique 
[24,25] applied to the determination of several analytes in different matrices. It is based on a ternary 
solvent system in which the extraction solvent (e. g., dichloromethane, octanol or toluene) is dissolved 
in the miscible disperser solvent (e. g., methanol, acetonitrile or isopropanol) are rapidly injected into 
the liquid samples by using a syringe. The disperser solvent must be miscible also with the aqueous 
sample. At the beginning of the dispersion, exceedingly small droplets are formed that enable a 
maximal increase in mass transfer. These droplets then collapse to form the extractant phase 
containing the analytes in an extremely small volume, thus achieving high enrichment factors. 
Room-temperature ionic liquids (RTILs), a form of melting salts composed of organic cations 
and either organic or inorganic anions, have emerged as possible environmental friendly solvents 
[26,27] with the consequent wide applications in the separation sciences [28–31]. This is due to their 
unique properties, such as low volatility, chemical and thermal stability, and good solubilization 
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properties toward both organic and inorganic compounds. Thus, RTILs are progressively replacing 
the typical organic solvents in LLE. The RTILs have been used as extractants in DLLME (IL-
DLLME) in several studies such as the determination of nonsteroidal anti-inflammatory drugs in urine 
by HPLC–UV [32], aryloxyphenoxy-propionate herbicides in aqueous samples by HPLC–DAD [33], 
insecticides by HPLC–DAD [34], sudan dyes and phthalate plasticizers in food (high-risk solid 
condiments and sauces) by HPLC–DAD [35], organophosphorus pesticides (OPPs) in apple and pear 
by HPLC–DAD [36] or polyaromatic hydrocarbons by HPLC–FLD [37] in water samples. 
In a previous work, we have used a IL-DLLME combined with HPLC–UV for the 
determination of NFX and BNZ in human plasma [20]. This procedure yielded significant 
improvements over those previously reported in the literature and has several advantages, including 
high inter-day reproducibility (1.02% and 3.66% for nifurtimox and benznidazole, respectively) and 
extremely low detection limits (15.7 and 26.5 ng mL-1 for nifurtimox and benznidazole, respectively). 
The proposed methodology is inexpensive, simple, fast and requires small amount of sample, an 
advantage consistent with the practicability requirements in current clinical research or therapeutic 
monitoring. 
Based on a theoretical analysis, transference of NFX into breast milk is expected to be limited 
[38], and unlikely to lead to a significant exposure of the breastfed infant. On the other hand, up to 
date there are no theoretical or experimental data about transference of BNZ into human breast milk. 
According to safety, scientific and regulatory reasons, the evaluation of the potential exposure of 
children to antichagasic drugs through breast milk in mandatory. Based on these facts, studies about 
the degree of transference of BNZ and NFX into breast milk are required. Thus, a suitable procedure 
for sample pretreatment with a subsequent analytical procedure needs to be developed for a reliable 
drug determination in that biological matrix characterized by its complexity and variability. 
The use of multivariate experimental design techniques is becoming increasingly widespread 
in analytical chemistry and other sciences. Multivariate designs, which allow the simultaneous study 
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of several control variables, are faster to implement and more cost-effective than traditional univariate 
approaches [39]. The central composite design (CCD) [40] is one of the most used multivariate 
techniques which combines a two-level full or fractional factorial design with at least one point at the 
center of the experimental region (usually, the starting value for each variable near to what is believed 
the optimum value is located), and additional points (“star points”) selected to obtain properties such 
as rotatability or orthogonality to fit quadratic polynomials. Thus, CCD has been the most accepted 
experimental design for second-order models [41]. 
 
In this work, we applied IL-DLLME–HPLC–UV for the first time for the determination of 
BNZ and NFX in human breast milk. We optimized the critical experimental parameters controlling 
the extraction process (volume of ionic liquid, volume of disperser solvent, pH and concentration of 
potassium chloride) by using a multivariate approach known as CCD, which allows linear and 
quadratic effects of the significant variables, as well as the interactions between them, to be estimated.  
 
2 Materials and methods 
 
2.1 Chemicals and materials 
 
The RTIL 1-octyl-3-methylimidazolium hexafluorphosphate ([C8C1im][PF6]) was synthesized 
in our laboratory with a procedure adapted from the literature [42]. Reagents were of analytical grade 
or better: benznidazole (Roche, Buenos Aires, Industria Argentina), nifurtimox (Bayer, Leverkusen, 
Germany), potassium hexafluorophosphate, 98.0% (Aldrich, WI, USA), 1-methylimidazole, ≥99.0% 
(Merck, Hohenbrunn, Germany), 1-bromoctane, ≥99.0% (Aldrich, WI, USA), sodium hydroxide 
(Analar, Poole, England), potassium chloride, sodium phosphate dibasic anhydrous (Anedra, 
Argentina), potassium phthalate monobasic, ≥99.5% (Fluka, Buchs, Germany), methanol HPLC grade 
(Baker’s Analyzed, Phillipsburg, NJ, USA). Solutions were prepared with MilliQ® water. 
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The 100 and 25 μL microsyringes were supplied by Hamilton, (Reno, NV, USA) and Agilent 
Technologies (Australia), respectively. The micropipettes were purchased from Eppendorf (Hamburg, 
Germany). 
 
2.2 Instrumentation and chromatographic conditions 
 
An HP 1100 liquid chromatograph equipped with a binary pump, a thermostat-controlled 
column compartment, degasser and variable-wavelength detector connected to a Data Apex CSW 
workstation (Data Apex, Czech Republic) was used. Chromatographic analysis was performed on a 
250 x 4.6 mm ID (5 μm) Zorbax Eclipse XDB-C18 column (Agilent). Methanol/water (45:55 v/v) was 
used in the mobile phase. The organic phase was prefiltered through a 0.22 μm nylon membrane 
(Osmonics-Magna) and the aqueous phase was prefiltered through a 0.45 μm cellulose–nitrate 
membrane (Micron Separations). The detector was set at 320 nm for BNZ and 395 nm for NFX, at 
which wavelengths the RTILs studied absorb no radiation. The injector (Rheodyne Model 7725i, 
Cotati, CA, USA) was fitted with a 5 μL loop. The flow rate was set at 1 mL min-1. 
An Eppendorf 5417C/R centrifuge operating at 10 000 rpm for the optimization and 
quantification experiments were used. A Vortex Genie 2 (Scientific Industries, USA) mixer was used 
for mixing the aqueous and the ionic liquid phases. For the pH measurements, a combined glass 
Metrohm electrode in a commercial Accument AR 25 pH/mV/Ion/Meter (Fisher Scientific) pH meter 
was used. Water was purified with a Milli-Q system (Millipore). 
 
2.3 Human breast milk samples 
 
Eight breast milk samples of different patients were obtained from lactating mothers with 
Chagas disease treated with BNZ or NFX (BNZ 5–10 mg kg-1 d-1 every 12 h for 30 days, or NFX 10–
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15 mg kg-1 d-1 every 8 h for 30 days), who were enrolled in a clinical study approved by both ethical 
and research review committees of Ciudad Autónoma de Buenos Aires Children’s Hospital Dr. 
Ricardo Gutierrez, Buenos Aires City, Argentina. The patients were not taking abuse drugs or any 
other medication except BZN or NFX. The samples were taken from the patients between the fourth 
and the tenth day after the drugs were administered. Around 5 mL of breast milk per patient was 
collected in polypropylene flasks with lid, without additives. All samples were maintained in the 
freezer until use. 
 
2.4 Sample pretreatment 
Several types of mixtures, some of them taken from the literature [43], to eliminate the proteic 
and lipidic material were tested. The most efficient one consisted of a precipitation mixture of HClO4 
(0.15 M)/H3PO4 (0.15 M)/MeOH. In a 2.0 mL polypropylene microcentrifuge tube containing 250 μL 
of human breast milk free of the antichagasic drugs spiked with 5 μL of BNZ 486 mg L-1 and NFX 
574 mg mL-1, 800 μL of the precipitation mixture were added. Then all tubes were shook (high speed) 
during 2.0 min and incubated at 80°C for 60 min. Next the samples were centrifuged at 10,000 rpm 
for 20 min and the supernatant was separated from the solid material (lipids and proteins) with a 
Pasteur pipette. Then, 200 μL of the precipitation mixture were added to the remaining residue, 
shaken and centrifuged, the obtained supernatant was added to the first extract and filtered using a 
micro-mate interchangeable syringe (Popper & Sons, New Hyde Park, NY, USA) with 0.22 μm 
cellulose nitrate membrane filters. 
The resulting IL-DLLME procedure optimized by CCD was as follows: I) for NFX: 50 μL of 
a 2 M NaOH solution and 150 μL of KCl solution 30 (%, w/v) were added to the obtained 
supernatant. Then, 122 μL of a mixture of 42 μL of [C8C1im][PF6] (the extractant solvent) with 80 μL 
of MeOH (the dispersant solvent) were rapidly injected with a micro syringe and brought to 1.5 mL 
with MilliQ water. II) For BNZ, 100 μL of KCl solution 30 (%, w/v) and 45 μL of 2 M NaOH 
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solution were added to the obtained supernatant. Finally, 143 μL of a mixture of 42 μL of 
[C8C1im][PF6] with 101 μL of MeOH were rapidly injected and brought to 1.5 mL with MilliQ water. 
The obtained samples (I and II) are shaken in a vortex for 6.0 min and centrifuged at 10,000 
rpm for 20.0 min. The aqueous phase on top was removed with a Pasteur pipette. The obtained RTIL 
phase, measured five times by a calibrated microsyringe, was 40 ± 5 μL. Finally, 5 μL of the 
extractant was injected into the chromatographic column. All experiments were performed in 
triplicate. 
 
2.5 Experimental design and statistical analysis 
A four-factor CCD [44] for the pH, volume of ionic liquid (VIL), methanol volume (VMeOH), 
and KCl concentration (CKCl), with the center point replicated 12 times was used. Each of the eight 
axial and 12 factorial points were replicated twice, given a total of 60 individual experiments (runs). 
Table 1 shows the actual and codified compositions. The runs were randomized to exclude block 
effects. The percent recovery of BNZ and NFX (R% BNZ and R% NFX, respectively) were analyzed 
in duplicate in each run. 
A response surface methodology (RSM) was used to analyze the effect of the four 
independent variables on the responses using the second-order polynomial response surface with the 
corresponding interactions: 
   
 
mkjiijkm
kji
kjiijk
i ji
jiij
i
iiiii xxxxxxxxxxxY
4
1
4
1
4
1
4
1
2
0    (1) 
 
where Y is the corresponding response variable; xi are the codified independent variables, β0 the 
constant term, βi represents the coefficient of the linear parameters, βii corresponds to the parameters 
of the quadratic terms, βij, βijk, and βijkm are the coefficients of the interaction parameters, and  is the 
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residual associated with the experiment. A stepwise methodology was followed to determine the 
significant terms in Eq. (1). Differences in the computed parameters were considered significant when 
the computed probabilities were less than 0.05 (P< 0.05). 
All statistical analysis, generation of response surfaces, desirability functional analysis, 
optimization and 3D and contour plots were accomplished using the Expert Design (trial version 
7.1.6, Stat-Ease, Minneapolis, USA) statistical software. 
 
2.6 Optimization and verification 
The optimum experimental conditions calculated using the predictive equations derived by 
RSM were employed for the microextractions of BNZ and NFX. Finally, the results were statistically 
compared to the values predicted by the mathematical model. 
 
3 Result and Discussion 
3.1 Optimization of the IL-DLLME procedure by central composite design 
As discussed in the introduction, the CCD methodology has the advantage of reducing the 
number of trials allowing to find more accurately the optimal values of the different variables 
affecting the extraction performance and, simultaneously, to detect the presence of interactions 
between them. Therefore, using the optimal experimental parameters obtained in our previous work 
by using the “step-by-step” procedure for the determination of BNZ and NFX (Figure 1.a and 1.b, 
respectively) in human plasma [20] as the starting point, in this work we refined the optimization 
procedure to find the optimal parameters closer to the “real ones”, by applying a CCD procedure. 
Since the amount of available sample was low, we scaled the obtained parameters to work in a 
microscale level. The final procedure is detailed in Section 2.4. 
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The percent recovery, R%, was the response for which maximum values we pretend to obtain 
by changing each experimental factor. The type of extractant (RTIL), dispersant and type of salt were 
the same used in the “step-by-step” methodology previously mentioned [20]. Therefore the remaining 
factors, considered most influential on the responses, were included in the CCD: volume of RTIL, VIL; 
volume of dispersant, VMeOH, pH, and saline effect, for which the variable in this case is the KCl 
concentration, CKCl. The levels chosen for those variables correspond to values that are close to the 
corresponding optimal values obtained by the “step-by-step” procedure. 
3.2 CCD experiments and responses 
Considering the previously mentioned four selected variables, a CCD consisting of a 24 
factorial design with six star points positioned at ±α from the center of the experimental domain was 
carried out. The axial distance α was chosen with a value of 2.0 to fulfill the rotatability condition, 
i.e., the design generates information uniformly in all directions. The design was completed with six 
experiments at the central point, so that the number of degrees of freedom for the lack-of-fit equals 
that for replications. Therefore, the complete design consisted of 30 (i.e. 24 + 2 × 4 + 6) experiments. 
The conditions of each experiment corresponding to the CCD procedure are listed in Table 1. 
The experiments and their responses are presented in Supporting Information, Table S1. They were 
performed in a random order to ensure the independence of the results by minimizing the effect of 
uncontrolled factors. The obtained design was repeated a week later to obtain a duplicate. Thus, a 
total of 60 experiments were performed. These trials were divided into three blocks performed on 
three consecutive days. As a comparison, the “step-by-step” design used in our previous work [20] for 
determination of the same antichagasic drugs in human plasma required a total of 237 experiments 
(including replicates). 
The results obtained by the CCD were used to build a model based on linear-type interactions 
where each response was adjusted to a polynomial equation. In each model, the coefficients were 
calculated by multiple regressions using a backward elimination strategy. This strategy consisted of 
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initially building a model and then evaluating each term through an analysis of variance (ANOVA) 
test to eliminate one by one the non-significant terms (α = 0.05). The iteration stopped when all the 
remaining terms satisfied a desired probability level. The obtained model was finally validated by 
verifying that the same result was significant according to an ANOVA test with P<0.05 and that their 
lack of fit was not significant at P>0.05. 
The response surfaces for BNZ and NFX are shown in Eq. (2) and (3). 
R% (BNZ) = 44.61 + 1.15VIL – 3.01 pH (2) 
R% (NFX) = 116.82 – 0.87VIL – 27.66CKCl + 0.75VILCKCl (3) 
It can be observed that for BNZ the experimental variables affecting the extraction process are the 
volume of RTIL and pH, while for NFX the significant terms are the volume of RTIL, the 
concentration of KCl and the interaction between them (VILCKCl). For both drugs, the volume of 
dispersant is not relevant in the final recovery. The extraction and centrifugation times were not 
considered in the CCD because adding one or two experimental factors increased significantly the 
number of experiments required. Therefore, for the extraction and centrifugation times we selected the 
optimal values obtained by the “step-by-step” procedure, i.e., 6.0 and 20.0 min, respectively. 
The next step was to find the factor conditions (volume of ionic liquid, volume of dispersant, 
concentration of KCl and pH) that maximized the response. Figures 2.a and 2.b show the response 
surfaces for both analytes. For BNZ, the surface diagram shows that R% increases linearly with the 
volume of the RTIL (as expected since more analyte is extracted) and with decreasing pH. Since no 
pKa data is available for these antichagasic drugs, no conclusions can be extracted from this last result. 
For NFX it can be observed that R% increases linearly with the increasing volume of the RTIL and 
with decreasing KCl concentration. This latter behavior could be surprising if the “salting-out” effect 
is the only factor considered. However, it was previously observed that coulombic interactions 
between the ions of the LI and the added salt can be present [20]. This phenomenon increases the 
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solubility of the RTIL into the aqueous phase with the consequent increasing of analyte solubility in 
this phase. 
From a simple visual inspection of the response surfaces, it is not possible to find one optimal 
experimental condition, i.e., the best combination of levels of the four factors necessary to achieve 
simultaneously the maximum responses. Thus, to optimize the responses for each compound, the 
Desirability function, D, approach [45] was used. Each Di function takes values between 0 and 1, 
where 0 corresponds to a completely undesirable value and 1 to a completely desirable one, i.e., an 
ideal response. The optimum values were obtained by using the corresponding fitted model and 
selecting the optimization criterion to be achieved for each compound. All factors were also included 
in the simultaneous optimization procedure to prioritize the use of certain more desirable conditions 
within the experimental region. In both cases the desirable ranges for the variables were selected and 
established whether it should be maximized, minimized, remain within a range or reach a target value. 
The approach used in this case corresponds to maximize R%. The predicted conditions that 
maximized the recovery of the IL-DLLME are shown in Table 2. The overall D function under these 
conditions was equal to 0.957 and 1.000 for the BNZ and NFX, respectively, which show that the 
optimum values obtained with the CCD model correctly predict the maximum percent recovery of the 
analytes. The predicted maximum recoveries were 78.0 and 91.87% for BNZ and NFX, respectively. 
In Section 3.3 these values are compared with the experimental ones. 
It can be observed in Table 2 that the optimal values predicted by the CCD procedure are: i) 
for the volume of ionic liquid, somewhat higher than the ones determined by the step-by-step 
procedure; ii) for the dispersant volume (methanol), higher in the case of BNZ but lower in the case of 
NFX; iii) for the pH, lower in the case of BNZ and almost equal for NFX and; vi) for the KCl 
concentration, almost equal in the case of BNZ but higher in the case of NFX. These differences can 
be attributed to the fact that, unlike the empirical step-by-step procedure, the CCD is a statistical 
methodology, which can predict values for the different variables closer to the real ones and also, to 
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the fact that the extraction experiments were performed on very different matrices (human breast milk 
vs. ultrapure water). 
 
3.3 Validation of the proposed IL-DLLME–HPLC–UV methodology 
Matrices can affect the analyte response by two different mechanisms: i) due to the matrix 
components present at the time of measuring, or ii) some components coming from the sample 
pretreatment, indispensable because of the matrix interferences. Any operation to which the sample is 
subjected before the measurement can result in a matrix effect. Thus, their effects must be studied. 
 
3.4 Matrix effect studies 
To study the matrix effects, different calibration curves (see Table 3) obtained by spiking 
with BNZ and NFX three different samples of human breast milk with no initial content of the drugs 
were constructed. Then, the slopes obtained by linear regression for the different samples were 
statistically compared by using a t-test at 5% probability (P = 0.05) [46]. It is observed in Table 4 
that, in all instances, tcalculated > t´tabulated, that is there were significant differences between slopes using 
different breast milk samples, so matrix effects were therefore present. As a consequence, for the 
quantification of BNZ and NFX in human breast milk samples, the standard addition method was 
used for each milk sample. 
 
3.5 Figures of merit 
 
As an internal validation of the proposed IL-DLLME–HPLC–UV methodology, the 
following figures of merit were evaluated: accuracy, repeatability, reproducibility, LOD, lower and 
upper LOQ, the linear range (LR), enrichment factor (EF), and extraction recovery (R%).  
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The LOD was calculated by two procedures to compare with other studies in the literature: 
S/N = 3.0 and the IUPAC definition of LOD= 3.29 so, where so is the SD of the blank [46]. The lower 
LOQ was evaluated as S/N = 10.0 and by the IUPAC definition of LOQ= 10 so [46]. The upper LOQ 
was determined by the lack-of-fit procedure [46], i.e., by eliminating the highest value and applying 
the statistical test again with the remaining points. This process is repeated until the data can be 
adjusted to a straight line. The linear range (LR) is defined by the lower and the upper LOQs. LOD 
and LOQ values for both drugs are shown in Table 5. 
To validate the accuracy and precision of the determinations, the samples of human breast 
milk (without initial content of the drugs) were spiked with each target drug at three different 
concentration levels within the linear range of the calibration curve. The precision was determined by 
the repeatability (intra-day) and reproducibility (inter-day determinations) with samples containing 
5.0, 10.0, and 15.0 μg mL-1 of NFX and BNZ. Repeatability and reproducibility were expressed as the 
RSD% with respect to measurements made in triplicate. The same drug concentrations were analyzed 
over three consecutive days to determine inter-day precision. The accuracy was determined by spiking 
the sample without analyte (“blank milk”) with known amounts of the standards and calculating the 
percentage relative error by using the actual and found concentrations. The results are summarized in 
Table 6. The enrichment factors (EFs) and recoveries (R%) were calculated by using Eq. (4) and (5), 
respectively. 
 
IL
aq
CEF
C
    (4) 
 
where CIL and Caq are the analyte concentrations in the IL phase and the initial aqueous solution, 
respectively 
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     (5) 
 
where VIL and Vaq are the volumes of the IL phase and the sample solution, respectively, and φ is the 
phase ratio. Human breast milk samples were spiked with known amounts of NFX and BNZ 
solutions, so the final concentrations were 2.5, 5.0, 7.5, 10.0 and 15.0 μg mL-1. The concentrations of 
the target analytes in the extracts were within the linear range of the calibration curves. The EF was 
determined by spiking a measured amount of analyte in a known volume of human breast milk and 
then determining the final concentration extracted into the RTIL phase. The analyte was left in 
contact with the human breast milk matrix for 1 h before extraction. The R% was determined by 
measuring the initial volume of spiked human breast milk and the final volume of RTIL phase and 
using the EF parameter. The R% obtained for NFX at different concentration levels were higher than 
those for BNZ (Table 7), but close to the recoveries predicted by the RSM procedure (91.9 and 
78.0%, respectively). Figure 3 shows the typical chromatograms of the two antichagasic drugs before 
and after IL-DLLME, in a spiked human breast milk sample. 
 
3.6 Comparison of the proposed methodology with other procedures from literature 
 
No analytical techniques to determine NFX in human breast milk were found in the literature. 
Thus, a comparison with the figures of merit obtained in the present paper is not possible. For BNZ, 
the obtained results were compared with the ones obtained by Marson et al. [22]. They used a tandem 
microfiltration system after protein precipitation and HPLC–UV analysis, with no preconcentration 
step. They have calculated the LOD by using the current definition of IUPAC (3.3 Sb/b, where Sb is 
the intercept standard error and b is the slope of the calibration curve). The obtained LOD was 0.3 μg 
mL-1, LOQ (9 Sb/b) of 0.9 μg mL-1, a R% of 70% with a precision lower than 10% and a linear range 
of 0.9 to 15 μg mL-1, intra-day accuracy of 6.6% and intra-day precision of 2.1%. These LODs and 
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LOQs cannot be compared with the ones obtained in the present study since the definitions used are 
different. However, the LODs and LOQs obtained here were calculated by a more rigorous procedure 
than that used in Ref. [22]. On the other hand, the R% (78%) was higher in this work, with a better 
precision (1.5%) than that reported in Ref. [22]. Also, in this work, a wider linear range was obtained: 
from the LOQ (the value depends on the used procedure of IUPAC or S/N ratio) to 29.16 μg mL-1 as 
compared with 0.9 to 15 μg mL-1 obtained by Marson et al. [22]. Finally, intra-day accuracy and intra-
day precision of 1.96% obtained in this work can be compared with 6.6 and 2.1% obtained in Ref. 
[22]. Thus, the recoveries and the upper LOQ were higher and the intra-day accuracy is lower in the 
present work. 
3.7 Analysis of BNZ and NFX in human breast milk 
 
As explained in Section 3.3, quantitative determinations were made by the standard addition 
method. Thus, linear regression of the peak areas vs. standard concentration at eight concentration 
levels made by triplicate (three different samples analyzed) were prepared. In Table 8 the 
antichagasic drug contents of human breast milk samples determined after the IL-DLLME–HPLC–
UV procedure are shown. For one sample of a patient treated with BNZ and for two samples of 
patients treated with NFX the drug was detected bellow the LOQ. For the other human breast milk 
samples, amounts of both drugs in the ppm range could be quantified precisely. 
 
4 Concluding remarks 
 
In this work, a simple and efficient method to quantify benznidazole and nifurtimox in human 
breast milk was developed. The methodology consists of a simple sample pre-treatment followed by 
an ionic liquid based dispersive liquid–liquid microextraction combined with LC and UV detection. 
For the extraction/preconcentration step, the ionic liquid 1-octyl-3-methylimidazolium 
hexafluorophosphate has been used as the “extraction solvent”. A factorial design, called central 
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composite design was used to find the optimum values for the significant variables affecting the 
extraction process: volume of ionic liquid, volume of disperser solvent, ionic strength and pH. The pH 
and volume of ionic liquid were the most influential parameters affecting the extraction of 
benznidazole, while for nifurtimox, the volume of ionic liquid, the ionic strength and an interaction 
term (volume of ionic liquid x KCl concentration) were significant. 
The analytical technique is simple, fast, requires small amounts of extraction solvent, which is 
an environmentally friendly compound, and exhibits a wide range of linearity, very low limits of 
detection and quantification, excellent reproducibility intra- and inter-days and high recoveries for 
both antichagasic drugs. 
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Figure 1. Chemical structures of (a) nifurtimox (NFX) and (b) benznidazole (BNZ). 
 
 
www.jss-journal.com Page 23 Journal of Separation Science 
 
 
This article is protected by copyright. All rights reserved. 
 
Figure 2. Surface response plots of: a) percentage recovery of benznidazole (R% BNZ) as a function 
of pH and volume of ionic liquid (VIL), using MeOH volume =93.84 μL and 2.0 (%, w/v) KCl; b) 
percentage recovery of nifurtimox (R% NFX) as a function of KCl content (CKCl) and VIL, (VMeOH = 
84 μL and pH = 6). 
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Figure 3. Chromatograms for protein-free human-breast milk sample spiked with BNZ (a) and NFX 
(b) at 2.5 μg mL-1 before (dotted line) and after (solid line) IL-DLLME preconcentration. 
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Table 1. Actual and codified factors: ionic liquid volumen (VIL), dispersant volumen (VMeOH), ionic 
strength (KCl concentration, CKCl) and pH values according with the central composite design used. 
 
 Codified factors 
Actual Factors -2 -1 0 +1 +2 
VIL (μL) 28 31.5 35 38.5 42 
VMeOH (μL) 56 70 84 98 112 
CKCl (%, w/v) 1 1.5 2 2.5 3 
pH 5 5.5 6.0 6.5 7 
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Table 2. Comparison between the optimal values found for the considered variables for the IL-
DLLME obtained by the CCD and by the “step-by-step” [20] procedures. 
 
  Factor   
Compound VIL (μL) VMeOH (μL) pH CKCl (%, w/v) 
BNZ 42 101.2 5.00 1.98 
NFX 42 80.0 5.91 2.97 
step-by-stepa) 35 84.0 6.12 2.00 
a) optimal values, for both compounds in ultrapure water, found in our previous work [20]. 
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Table 3. Calibration curves for NFX and BNZ after IL-DLLME of three samples without initial analyte 
content.  
 
Analyte  Linear regression r2 a) N b) 
BNZ    
Sample 1  y= (-24.0 ± 8.2) + (3.5± 0.2)x 0.9724 24 
Sample 2 y= (-14.2 ± 4.7) + (4.0± 0.1)x 0.9900 19 
Sample 3 y= (-12.2 ± 4.3) + (4.42 ± 0.08)x 0.9969 19 
NFX    
Sample 1 y= (-38.1 ± 16.1) + (4.5 ± 0.4)x 0.9327 22 
Sample 2 y= (-54.2 ± 9.8) + (6.8 ± 0.2)x 0.9936 22 
Sample 3 y= (-121 ± 18) + (7.9 ± 0.3)x 0.9929 22 
a) r2 = determination coefficient. 
b) N = number of points. 
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Table 4. t-Test at 5% probability for comparison of the calibration curves slopes obtained in Table 3. 
 
Comparison of slopes t (calculated) t´(tabulated) 
BNZ   
Samples 1-2 2.020 2.010 
Samples 1-3 4.660 2.084 
Samples 2-3 2.843 2.109 
NFX   
Samples 1-2 5.374 2.090 
Samples 1-3 7.200 2.042 
Samples 2-3 3.464 2.042 
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Table 5. Limits of detection (LOD) and quantification (LOQ) obtained for BNZ and NFX in human 
breast milk (concentration units in μg mL-1). 
 
Analyte  Linear range  LODa) LODb) LOQc) LOQb) 
BNZ LOQ-29.16 0.09 0.29 0.30 0.88 
NFX LOQ-34.40 0.06 0.18 0.20 0.55 
 a) S/N= 3. 
  b) From calibration curve (actual IUPAC definition). 
 c) S/N= 10. 
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Table 6. Quantitative determinations of NFX and BNZ in spiked human breast milk, accuracy and 
reproducibility (concentrations in μg mL-1). 
 
Analyte Cadded (μg mL-1) Cfound (μg mL-1) Accuracy (%)a) Precision RSD (% )b) 
NFX     
Intra-day 5.0 4.8±0.3 -4.16 4.16 
 10.0 9.7±0.3 -3.09 1.55 
 15.0 14.5±0.2 -3.44 0.68 
Inter-day 5.0 5.2±0.5 3.85 5.77 
 10.0 9.8±0.3 -2.04 2.04 
 15.0 14.8±0.4 -1.35 2.02 
BNZ     
Intra-day 5.0 5.1±0.2 1.96 1.96 
 10.0 9.8±0.3 -2.04 2.04 
 15.0 14.7±0.3 -2.04 1.36 
Inter-day 5.0 4.8±0.4 -4.16 6.25 
 10.0 9.7±0.4 -3.09 2.06 
 15.0 14.6±0.5 -2.73 2.05 
a) relative error percent; Er(%)= ((Cadded-Cfound)/Cadded) x 100. 
b) SD/ X av x 100. 
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Table 7. Enrichment factors (EF), recoveries (R%) and their RSD% for human breast milk samples at 
different spiked levels of NFX and BNZ. 
 
 NFX  BNZ 
C (μg mL-1) EF R(%)a) RSD(%)b)  EF R(%)
a) 
RSD(%)b) 
2.5 33.8 90.0 1.2  28.8 76.8 1.5 
5.0 33.5 89.3 0.8  29.0 77.3 0.9 
7.5 33.0 90.8 0.8  28.6 76.3 0.9 
10.0 33.0 90.6 1.0  29.3 78.1 1.0 
15.0 32.8 87.8 0.7  29.6 78.9 0.6 
 RSM c)   91.9    78.0  
a) R% at n= 3. 
b) SD/ X av x 100 calculated for recovery. 
c) Predicted by the Response Surface Methodology.  
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Table 8. Quantification of  BNZ and NFX in eight human breast milk samples of different patients 
treated with each of the drugs. (samples were analized in triplicate). 
  
BNZ NFX 
Sample C (μg mL-1) Sample C (μg mL-1) 
Sample 1 7.1±0.3 Sample 1 <LOQ 
Sample 2 5.2±0.4 Sample 2 8.2±0.3 
Sample 3 3.1±0.3 Sample 3 8.1±0.4 
Sample 4 <LOQ Sample 4 <LOQ 
 
 
 
 
 
 
 
 
